2023
DOI: 10.1016/j.jep.2022.115745
|View full text |Cite
|
Sign up to set email alerts
|

Anadenanthera colubrina (Vell) Brenan: Ethnobotanical, phytochemical, pharmacological and toxicological aspects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 86 publications
0
2
0
Order By: Relevance
“…Worldwide, more than 50,000 plant species are documented for their clinical benefits and pharmacological effects on humans and domestic animals (Sharma et al 2022). Studies show that 80% of the world's population uses medicinal plants or their bioactive compounds for the prevention, cure or treatment of several diseases (Macía et al 2005;Ajibesin et al 2012;Chiribagula et al 2020;Mlilo and Sibanda 2022;Ugbogu et al 2022;Delices et al 2023). In developing countries, the use of herbal medicines as an alternative to modern medicine is very common (Nath and Puzari 2022).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Worldwide, more than 50,000 plant species are documented for their clinical benefits and pharmacological effects on humans and domestic animals (Sharma et al 2022). Studies show that 80% of the world's population uses medicinal plants or their bioactive compounds for the prevention, cure or treatment of several diseases (Macía et al 2005;Ajibesin et al 2012;Chiribagula et al 2020;Mlilo and Sibanda 2022;Ugbogu et al 2022;Delices et al 2023). In developing countries, the use of herbal medicines as an alternative to modern medicine is very common (Nath and Puzari 2022).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the increase in the use of traditional medicine in both developing (such as DR Congo) and developed countries can be explained by several factors. The first factor is related to the discovery in plants of secondary metabolites that have different pharmacological potentials (Delices et al 2023). The second factor is the low cost of treatment (in terms of consultation and consumption of medicinal plants) compared to conventional medicine which is based on overpriced commercial pharmaceuticals (Macía et al 2005;Kasika et al 2015;Kasika et al 2016;Basak et al 2022;Ginko et al 2023).…”
Section: Introductionmentioning
confidence: 99%